What is another word for Fumarylacetoacetase Deficiency Disease?
Pronunciation: [fjˈuːmɑːɹˌɪlɐsˌɛtə͡ʊsˌɛte͡ɪs dɪfˈɪʃənsi dɪzˈiːz] (IPA) 
Fumarylacetoacetase Deficiency Disease, also known as FAAD, is a rare genetic disorder that affects the metabolism of a certain amino acid called tyrosine. This condition is caused by a mutation in the Fumarylacetoacetase (FAH) gene, which leads to a deficiency or absence of the enzyme responsible for breaking down tyrosine in the body. FAAD can result in a buildup of toxic substances that can damage various organs, primarily the liver and kidneys. Although there are no direct synonyms for the term "Fumarylacetoacetase Deficiency Disease", it may be referred to as FAAD or simply FAH deficiency, which are commonly used abbreviations in the medical field.
